Correlation Between Travere Therapeutics and Ikena Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Ikena Oncology, you can compare the effects of market volatilities on Travere Therapeutics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Ikena Oncology.

Diversification Opportunities for Travere Therapeutics and Ikena Oncology

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Travere and Ikena is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Ikena Oncology go up and down completely randomly.

Pair Corralation between Travere Therapeutics and Ikena Oncology

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 3.14 times more return on investment than Ikena Oncology. However, Travere Therapeutics is 3.14 times more volatile than Ikena Oncology. It trades about 0.26 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.08 per unit of risk. If you would invest  905.00  in Travere Therapeutics on August 25, 2024 and sell it today you would earn a total of  920.00  from holding Travere Therapeutics or generate 101.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Travere Therapeutics  vs.  Ikena Oncology

 Performance 
       Timeline  
Travere Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Travere Therapeutics and Ikena Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Travere Therapeutics and Ikena Oncology

The main advantage of trading using opposite Travere Therapeutics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.
The idea behind Travere Therapeutics and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stocks Directory
Find actively traded stocks across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world